Transcriptomics

Dataset Information

0

RNA-seq analysis of RRN3 knockdown in HCT116 cells

ABSTRACT: Ribosome biosynthesis is essential for cancer growth and proliferation. This dependency is therapeutically exploitable by blocking the rate-limiting step, RNA polymerase I (Pol I) transcription. Here we investigated the effects of knockdown RNA Pol I component RRN3. expression of mRNA genes.

ORGANISM(S): Homo sapiens

PROVIDER: GSE282213 | GEO | 2025/05/13

REPOSITORIES: GEO

Json Xml

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

Transcriptomics RNA-seq analysis of RNA polymerase I inhibitor in HCT116 cells
2025-05-13 | GSE282212 | GEO
Transcriptomics RNA-seq analysis of RNA polymerase I inhibitor in p53 null HCT116 colon adenocarcinoma cells.
2025-05-13 | GSE267502 | GEO
Transcriptomics RNA-seq analysis of RNA polymerase I inhibitor in p53 proficient HCT116 colon adenocarcinoma cells
2025-05-13 | GSE267501 | GEO
Transcriptomics RNA-seq analysis of parent, RPL22L1 knockout and RPL22 reconstituted HCT116 cells.
2025-05-13 | GSE267500 | GEO
Transcriptomics RNA-seq analysis of RNA polymerase I inhibitor in A375 melanoma cells.
2025-05-13 | GSE282214 | GEO
Transcriptomics RNA-seq analysis of RNA polymerase I inhibitor in A375 melanoma cells
2025-05-13 | GSE267499 | GEO
Genomics ChIP-seq analysis of RNA polymerase I inhibitor effect on Pol I and Pol II binding
2025-05-13 | GSE267504 | GEO
Other GoldCLIP-seq analysis of RPL22HaloTag and RPL22L1HaloTag RNA-binding
2025-05-13 | GSE267503 | GEO
Genomics Arginine dependency is a therapeutically exploitable vulnerability in chronic myeloid leukaemic stem cells
| PRJNA941940 | ENA
Transcriptomics RSK1 is an exploitable dependency in myeloid malignancies [CD14_RNAseq]
2024-12-06 | GSE283711 | GEO